Pharmacovigilance Risk Assessment Committee (PRAC): 25-29 September 2017

  • Email
  • Help


TitlePharmacovigilance Risk Assessment Committee (PRAC): 25-29 September 2017
Date25/09/2017 - 29/09/2017
LocationEuropean Medicines Agency, London, UK
SummaryThe Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

All documents

Name Language First published Last updated
Minutes of the PRAC meeting 25-29 September 2017 (English only) 2017-11-24  
Agenda - PRAC draft agenda of meeting 25-29 September 2017 (English only) 2017-09-25  
Agenda - Public hearing: Valproate (English only) 2017-09-22 2017-09-25
Summary of the EMA public hearing on valproate in pregnancy (English only) 2017-10-04  
Public hearing on valproate - Written interventions (English only) 2017-10-02  
Summary of safety concerns and list of questions for the public hearing on Valproate (English only) 2017-07-11  

Media Videos

Video recording of public hearing

The PRAC held a public hearing on valproate and related substances on 26 September 2017.

small format video Icon To watch the video recording, click on the 'Multimedia' tab.

To view the documents for the public hearing, click on the 'Documents' tab.

Related information